DSC MRI Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
==DSC MRI Meetings== | ==DSC MRI Meetings== | ||
'''Recent Approved call summaries:''' | '''Recent Approved call summaries:''' | ||
<br />Note: The last meeting of this group was held on | <br />Note: The last meeting of this group was held on September 9, 2020; notes are posted after they are approved by the DSC-MRI BC during the following t-con | ||
*[[Media:2020_07-08_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|July 8, 2020]] | *[[Media:2020_07-08_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|July 8, 2020]] | ||
| Line 21: | Line 21: | ||
* Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page | * Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page | ||
==Profile Development== | ==Profile Development== | ||
Revision as of 23:25, 29 September 2020
- Co-chairs: Bradley Erickson, MD, PhD; Ona Wu, PhD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
Develop a quantitative imaging profile for Dynamic Susceptibility Contrast MRI.
DSC MRI Meetings
Recent Approved call summaries:
Note: The last meeting of this group was held on September 9, 2020; notes are posted after they are approved by the DSC-MRI BC during the following t-con
DSC-MRI Call Summaries Archive
- Earlier materials can be found on the PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee page
Profile Development
- DSC Profile Stage 1 Version for Public Comment (comments closed on May 15, 2020)
- DSC Profile Stage 2 Consensus Profile - to be released soon
Historical Background - Formation of the Group
Reference Materials
QIBA Funded Projects
Round 5
Original Proposal to the QIBA Steering Committee